Genetic selection for modulators of the MAP kinase and β-catenin growth-control pathways in mammalian cells

Biochemical Genetics

Volumn 40, Issue 11-12, 2002, Pages 359-378

  Wheatley, William ^a   Yoo, Sanghee ^b   Pierce, Michael ^a   Rebentisch, Matthew ^a   Endo, Mark ^a   Peterson, Isaac ^a   Stump, Mark ^a   McCormack, Ken ^b   Garcia Guzman, Miguel ^b   Kamb, Alexander ^a  

^a Arcaris Incorporated   (United States)

^b Aurora Biosciences Corporation   (United States)

Author keywords

catenin; Cadherin; MAP kinase; Peptide; Raf; Transdominant genetics; TrkB

Indexed keywords

BETA CATENIN; CADHERIN; MITOGEN ACTIVATED PROTEIN KINASE; RAF PROTEIN; CATNB PROTEIN, MOUSE; CYTOSKELETON PROTEIN; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; CELL GROWTH; ENZYME REGULATION; GENETIC SELECTION; GROWTH REGULATION; HUMAN; HUMAN CELL; MAMMAL CELL; NONHUMAN; PROTEIN DETERMINATION; TRANSACTIVATION; YEAST; ANIMAL; BIOASSAY; CELL STRAIN 3T3; GENETICS; IN VITRO STUDY; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALIA; MAMMALIA;

3T3 CELLS; ANIMALS; BETA CATENIN; BIOLOGICAL ASSAY; CYTOSKELETAL PROTEINS; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; SELECTION (GENETICS); SIGNAL TRANSDUCTION; TRANS-ACTIVATORS;

EID: 1842865985     PISSN: 00062928     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020705210855     Document Type: Article

References (39)

1. Abedi, M. R., Caponigro, G., and Kamb, A. (1998). Green fluorescent protein as a scaffold for intracellular presentation of peptides. Nucleic Acids Res. 26(2):623-630.
2. Baeg, G. H., Matsumine, A., Kuroda, T., Bhattacharjee, R. N., Miyashiro, I., Toyoshima, K., and Akiyama, T. (1995). The tumour suppressor gene product APC blocks cell cycle progression from G0/G1 to S phase. EMBO J. 14(22):5618-525.
3. Behrens, J. (2000). Control of beta-catenin signaling in tumor development. Ann. N. Y. Acad. Sci. 910:21-33; discussion 33-35.
4. Blum, J. H., Dove, S. L., Hochschild, A., and Mekalanos, J. J. (2000). Isolation of peptide aptamers that inhibit intracellular processes. Proc. Natl. Acad. Sci. U.S.A. 97(5):2241-2246.
5. Caponigro, G., Abedi, M. R., Hurlburt, A. P., Maxfield, A., Judd, W., and Kamb, A. (1998). Transdominant genetic analysis of a growth control pathway. Proc. Natl. Acad. Sci. U.S.A. 95(13):7508-7513.
6. Chan, R. K., and Otte, C. A. (1982). Physiological characterization of Saccharomyces cerevisiae mutants supersensitive to G1 arrest by a factor and alpha factor pheromones. Mol. Cell. Biol. 2(1):21-29.
7. Chen, C., and Okayama, H. (1987). High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7(8):2745-2752.
8. Deiss, L. P., and Kimchi, A. (1991). A genetic tool used to identify thioredoxin as a mediator of a growth inhibitory signal. Science 252(5002):117-120.
9. Der, C. J., and Cooper. G. M. (1983). Altered gene products are associated with activation of cellular rasK genes in human lung and colon carcinomas. Cell 32(1):201-208.
10. Dunn, S. J., Park, S. W., Sharma, V., Raghu, G., Simone, J. M., Tavassoli, R., Young, L. M., Ortega, M. A., Pan. C. H., Alegre, G. J., Roninson, I. B., Lipkina, G., Dayn, A., and Holzmayer, T. A. (1999). Isolation of efficient antivirals: Genetic suppressor elements against HIV-1. Gene Ther. 6(1):130-137.
11. Feldhaus, M. J., Lualhati, M., Cardon, K., Roth, B., and Kamb, A. (2000). Oligonucleotide-conjugated beads for transdominant genetic experiments. Nucleic Acids Res. 28(2):534-543.
12. Garkavtsev, I., Grigorian, I. A., Ossovskaya, V. S., Chernov, M. V., Chumakov, P. M., and Gudkov, A. V. (1998). The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control. Nature 391(6664):295-298.
13. Geyer, C. R., Colman-Lerner, A., and Brent, R. (1999). "Mutagenesis" by peptide aptamers identifies genetic network members and pathway connections. Proc. Natl. Acad. Sci. U.S.A. 96(15):8567-8572.
14. Gradl, D., Kuhl, M., and Wedlich, D. (1999). The, Wnt/Wg signal transducer beta-catenin controls fibronectin expression. Mol. Cell. Biol. 19(8):5576-5587.
15. Gudkov, A. V., Kazarov, A. R., Thimmapaya R., Axenovich, S. A., Mazo, I. A., and Roninson, I. B. (1994). Cloning mammalian genes by expression selection of genetic suppressor elements: Association of kinesin with drug resistance and cell immortalization. Proc. Natl. Acad. Sci. U.S.A. 91(9):3744-3748.
16. Holzmayer, T. A., Pestov, D. G., and Roninson, I. B. 1992). Isolation of dominant negative mutants and inhibitory antisense RNA sequences by expression selection of random DNA fragments. Nucleic Acids Res. 20(4):711-717.
17. Huber, A. H., and Weis, W. I. (2001). The structure of the beta-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin. Cell 105(3):391-402.
18. Kamb, A., and Teng, D. H.-F. (2000). Transdominant genetics peptide inhibitors, and drug targets. Curr. Opin. Mol. Therapeut. Genom. Proteom 6:662-669.
19. Kruger, M., Beger, C., Li, Q. X., Welch, P. J., Tritz, R., Leavitt, M., Barber, J. R., and Wong-Staal, F. (2000). Identification of eIF2B gamma and eIF2gamma as cofactors of hepatitis C virus internal ribosome entry site-mediated translation using a functional genomics approach. Proc. Natl. Acad. Sci. U.S.A. 97(15):8566-8571.
20. Li, Y., Bollag, G., Clark. R., Stevens, J., Conroy, L., Fults, D., Ward, K., Friedman, E., Samowitz, W., Robertson, M., Bradley, P., McCormick, F., White, R., and Cawthan, R. (1992). Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell 69(2):275-281.
21. Lin, K., Wang, S., Julius, M. A., Kitajewski, J., Moos., M., Jr., Luyten, F. P. (1997). The cysteine-rich frizzled domain of Frzb-1 is required and sufficient for modulation of Wnt signaling. Proc. Natl. Acad. Sci. U.S.A. 94(21):11196-11200.
22. Munemitsu, S., Albert, I., Souza, B., Rubinfeld, B., and Polakis, P. (1995). Regulation of intracellular betacatenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc. Natl. Acad. Sci. U.S.A. 92(7):3046-3050.
23. Murray, M. J., Cunningham, J. M., Parada, L. F., Dautry, F., Lebowitz, P., and Weinberg, R. A. (1983). The HL-60 transforming sequence: A ras oncogene coexisting with altered myc genes in hematopoietic tumors. Cell 33(3):749-757.
24. Norman, T. C., Smith, D. L., Sorger, P. K., Drees, B. L., O'Rourke, S. M., Hughes, T. R., Roberts, C. J., Friend, S. H., Fields, S., and Murray, A. W. (1999). Genetic selection of peptide inhibitors of biological pathways. Science 285(5427):591-595.
25. Playford, M. P., Bicknell, D., Bodmer, W. F., and Macaulay, V. M. (2000). Insulin-like growth factor I regulates the location, stability, and transcriptional activity of beta-catenin. Proc. Natl. Acad. Sci. U.S.A. 97(22):12103-12108.
26. Ramer, S. W., Elledge, S. J., and Davis, R. W. (1992). Dominant genetics using a yeast genomic library under the control of a strong inducible promoter. Proc. Natl. Acad. Sci. U.S.A. 89(23):11539-11593.
27. Reznikoff, C. A., Brankow, D. W., and Heidelberger, C. (1973). Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. Cancer Res 33(12):3231-3238.
28. Sandrock, T. M., Risley B., Richards, B. T., Poritz, M. A., Austin, H. A., Yoo, S., Kim, M. K.-H., Roth, B., Repetny, K., Hsu, F., Stump, M., Teng, D. H.-F., and Kamb, A. (2001). Exogenous peptide and protein expression levels using retroviral vectors in human cells. J. Mol. Ther. 4(5):398-406.
29. Shimoyama, Y., Gotoh, Terasaki, T., Kitajima, M., and Hirohashi, S. (1995). Isolation and sequence analysis of human cadherin-6 complementary DNA for the full coding sequence and its expression in human carcinoma cells. Cancer Res. 55(10):2206-2211.
30. Stump, M. D., DiSera, L., Rebentisch, M., Endo, M., Pierce, M., and Kamb, A. (2002). An automated system for screening retroviral expression constructs in microplate format. J. Biomol. Screen. 7(3):275-280.
31. Sun, P., Dong, P., Dai, K., Hannon, G. J., and Beach, D. (1998). p53-independent role of MDM2 in TGF-betal resistance. Science 282(5397):2270-2272.
32. Tepass, U., Truong, K., Godt, D., Ikura, M., and Peifer, M. (2000). Cadherins in embryonic and neural morphogenesis. Nat. Rev. Mol. Cell. Biol. 1(2):91-100.
33. Tetsu, O., and McCormick, F. (1999). Beta-catenin regulates expression of cyclin D-in colon carcinoma cells. Nature 398(6726):422-426.
34. Troppmair, J., Bruder, J. T., Munoz, H., Lloyd, P. A., Kyriakis, J., Banerjee, P., Avruch, J., and Rapp, U. R. (1994). Mitogen-activated protein kinase/extracellular signal-regulated protein kinase activation by oncogenes, serum, and 12-O-tetradecanoylphorbol-13-acetate requires Raf and is recessary for transformation. J. Biol. Chem. 269(9):7030-7035.
35. Vojtek, A. B., and Der, C. J. (1998). Increasing complexity of the Ras signaling pathway. J. Biol. Chem. 273(32):19925-19928.
36. Wang, D., Liebowitz, D., and Kieff, E. (1985). An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43(3, part 2):831-840.
37. Whitehead, I., Kirk, H., and Kay, R. (1995). Retroviral transduction and oncogenic selection of a cDNA encoding Dbs, a homolog of the Db1 guanine nucleotide exchange factor. Oncogene 10(4):713-721.
38. Xu, G. F., O'Connell, P., Viskochil, D., Cawthon, R., Robertson, M., Culver, M., Dunn, D., Stevens. J., Gesteland, R., White, R., and Weiss, R. (1990). The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62(3):599-608.
39. Xu, X., Leo, C., Jang, Y., Chan, E., Padilla, D., Huang, B. C., Lin, T., Gururaja, T., Hitoshi, Y., Lorens, J. B., Anderson, D. C., Sikic, B., Luo, Y., Payan, D. G., Nolan, G. P. (2001). Dominant effector genetics in mammalian cells. Nat. Genet. 27(I):23-29.